SciClone Applies To Sell Liver Treatment In China
SciClone Pharmaceuticals Inc. (SCLN) submitted an application with the Chinese government to sell its liver cancer treatment in China. The stock price gained 53 cents to $3.42.
posted by FC Market News at 8:58 PM
0 Comments:
Post a Comment
<< Home